PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

46 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Mallett, S.* ; Timmer, A. ; Sauerbrei, W.* & Altman, D.G.*: Reporting of prognostic studies of tumour markers: A review of published articles in relation to REMARK guidelines. Br. J. Cancer 102, 173-180 (2010)
22.
Horsch, M. et al.: Overexpressed vs mutated Kras in murine fibroblasts: A molecular phenotyping study. Br. J. Cancer 100, 656-662 (2009)
23.
Stumpf, M.* et al.: Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: Relevance of clonal selection of T lymphocytes. Br. J. Cancer 101, 1513-1521 (2009)
24.
Aubele, M. et al.: Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br. J. Cancer 99, 1089-1095 (2008)
25.
Blechschmidt, K.* et al.: The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br. J. Cancer 98, 489-495 (2008)
26.
Hennig, R.* et al.: BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br. J. Cancer 99, 1064-1073 (2008)
27.
Atmaca, A.* et al.: Valproic acid (VPA) in patients with refractory advanced cancer: A dose escalating phase I clinical trial. Br. J. Cancer 97, 177-182 (2007)
28.
Aubele, M. et al.: PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br. J. Cancer 96, 801-807 (2007)
29.
Baeuerle, P.A.* & Gires, O.: EpCAM (CD326) finding its role in cancer. Br. J. Cancer 96, 417-423 (2007)
30.
Ruf, P.* et al.: Characterisation of the new EpCAM-specific antibody HO-3: Implications for trifunctional antibody immunotherapy of cancer. Br. J. Cancer 97, 315-321 (2007)
31.
Unger, K. et al.: RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. Br. J. Cancer 94, 1472-1477 (2006)
32.
Crispo, A.* et al.: The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br. J. Cancer 91, 1280-1286 (2004)
33.
Kreuzer, M.* ; Gerken, M. ; Kreienbrock, L. ; Wellmann, J. & Wichmann, H.-E.: Lung cancer in lifetime nonsmoking men : Results of a case-control study in Germany. Br. J. Cancer 84, 134-140 (2001)
34.
Kreuzer, M. et al.: Gender differences in lung cancer risk by smoking: A multicentre case-control study in Germany and Italy. Br. J. Cancer 82, 227-233 (2000)
35.
Zeidler, R.* et al.: The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumor cells. Br. J. Cancer 83, 261-266 (2000)
36.
Jacob, P. et al.: Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br. J. Cancer 80, 1461-1469 (1999)
37.
Eichholtz-Wirth, H. ; Reidel, G. & Hietel, B.: Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. Br. J. Cancer 67, 1001-1006 (1993)
38.
Eichholtz-Wirth, H. ; Reidel, G.* & Hietel, B.: Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. Br. J. Cancer 67, 1001-1006 (1993)
39.
Schultz-Hector, S. ; Begg, A.C. ; Hofland, I.D. ; Kummermehr, J.C. & Sund, M.: Cell kinetic analysis of murine squamous cell carcinomas: A comparison of single versus double labelling using flow cytometry and immunohistochemistry. Br. J. Cancer 68, 1097-1103 (1993)
40.
Wolf, D.A. ; Kohlhuber, F. ; Schulz, P. ; Fittler, F. & Eick, D.: Transcriptional Down-regulation of c-myc in Human Prostate Carcinoma Cells by the Synthetic Androgen Mibolerone. Br. J. Cancer 65, 376-382 (1992)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮